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4°75′Ε) during May–June 2010. All 
larvae were euthanized as part of an 
invasive species eradication project 
and stored at –20°C until further 
use. At necropsy, liver tissues were 
collected, and DNA was extracted 
by using the Genomic DNA Mini 
Kit (BIOLINE, London, UK). PCR 
to detect ranavirus was performed as 
described by Mao et al. (10).
Three samples showed positive 
results with this PCR. These samples 
were sequenced by using primers 
M4 and M5 described by Mao et al. 
(10) and blasted in GenBank. A 100% 
homology with the common midwife 
toad (A. obstetricans) ranavirus partial 
major capsid protein gene (GenBank 
accession no. FM213466.1) was 
found (5). Despite the low prevalence 
of Ranavirus infection (0.75%) in 
the bullfrog tadpoles examined, this 
study shows that invasive bullfrogs, a 
known reservoir of chytridiomycosis, 
are also a likely carrier of ranaviral 
disease in Europe.
This study was partly performed 
in the framework of European Union 
Interreg IVA project IVA-VLANED-2.31 
“Invasieve exoten in Vlaanderen en Zuid-
Nederland–INVEXO.”
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Rift Valley and 
West Nile Virus 
Antibodies 
in Camels, 
North Africa
To the Editor: Different 
arboviral diseases have expanded 
their geographic range in recent times. 
Of them, Rift Valley fever, West Nile 
fever, and African horse sickness 
are of particular concern. They are 
endemic to sub-Saharan Africa but 
occasionally spread beyond this area. 
Trade and transport of animals and 
animal products, along with wildlife 
movements, are considered the 
driving factors in the spread of these 
pathogens.
In wide regions of Africa, 
1-humped camels (Camelus 
dromedarius) are valuable livestock 
appreciated as a meat source and as 
a means for transportation of goods. 
Camels are susceptible to infection by 
Rift Valley fever virus (RVFV), West 
Nile virus (WNV), and African horse 
sickness virus (AHSV), although their 
epidemiologic role in these diseases is 
uncertain (1–3). Movements of camels 
across the Sahara Desert could carry 
these pathogens to northern Africa. To 
test this hypothesis, we conducted a 
serologic survey in 1-humped camels 
intercepted at different points by the 
Moroccan Veterinary Services in 
2009. The camels were coming from 
the southeastern part of the Sahara 
Desert going to the northwest. 
Serum samples were obtained 
in Smara-Laayoune, Dakhla, and 
Tata (Table). Most samples (71 of 
100 total samples) were from male 
camels. Samples were also grouped 
by age of the camels (Table). RVFV 
antibodies were detected by using a 
competitive ELISA (4), and samples 
yielding positive ELISA results were 
confi rmed by virus-neutralization 
test. WNV-specifi c antibodies were 
detected by ELISA (5), and positive 
results were confi rmed by virus-
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neutralization test. AHSV-specifi c 
antibodies were detected by using 
the ELISA prescribed by the World 
Organisation for Animal Health.
Fifteen of 100 samples were 
positive for RVFV-specifi c antibodies 
by competitive ELISA, all of which 
were confi rmed by virus-neutralization 
test, with neutralization titers ranging 
from 40 to 1,280 (geometric mean 
titer = 229). With regard to WNV 
antibodies, the ELISA detected 44 
positive samples and 1 doubtful 
sample, of which 29 were confi rmed 
as positive by virus-neutralization test 
(virus-neutralization test titers ranging 
from 10 to 640; geometric mean 
titer = 20). As for AHSV antibodies, 
none of the samples was positive by 
ELISA. Prevalence data were analyzed 
by generalized linear model with 
locality (Dakhla or Smara), sex, and 
age as fi xed factors. No differences by 
origin or sex were found in prevalence 
for WNV (p>0.14) but antibodies 
were more prevalent in camels >3 
years of age (χ2 = 14.04, 3 df, p = 
0.003). No differences in prevalence 
of RVFV antibodies were found by 
sex (p = 0.29), but prevalence was 
higher in Smara (χ2 = 3.74, p = 0.05) 
and among camels >6 years of age 
(χ2 = 8.37, df = 3, p = 0.04) (Table). 
We also examined the co-occurrence 
of antibodies to RVFV and WNV. Of 
15 RVFV-positive samples, 12 were 
also positive for WNV antibodies, and 
12 of 29 WNV-positive samples were 
also positive for RVFV (χ2 = 8.37, 
df = 1, p < 0.05).
Antibodies to 2 zoonotic 
arboviruses, i.e., RVFV and WNV, 
were present in camels moving to 
the northwestern part of the Sahara 
Desert, and antibodies to AHSV were 
absent in the populations examined. 
Despite the higher percentage of 
seropositivity for WNV than for 
RVFV, the epidemiologic consequence 
of RVFV-specifi c antibodies in this 
population could be higher than that 
for WNV antibodies. Camels can act 
as reservoir hosts for RVFV (6) but 
are unlikely to do so for WNV, which 
cycles between mosquitoes and wild 
birds with mammals usually being 
dead-end hosts. High prevalence of 
antibodies to RVFV in camels has been 
described in different sub-Saharan and 
Sahelian countries (7–9). Camels have 
been involved in the spread of disease 
in some instances (10). Immunity to 
RVFV indicates previous infection. 
Our results showed that seroprevalence 
of RVFV was higher among older 
than younger camels, indicating 
that contact could have occurred 
some years ago. Nevertheless, these 
populations should be monitored for 
RVFV and other arboviroses because 
these are known to reemerge under 
certain circumstances in locations 
where they have occurred in the past.
The results of this study support 
that camels moving across the Sahara 
have contact with RVFV and WNV, 
and frequently the same animals have 
been infected by both agents. In a 
particularly dry environment such as 
the desert, particular attention should 
be paid to singular wet areas such 
as oases. The presence of water in 
these areas results in an abundance 
of competent mosquitoes and hosts, 
which in turn makes these viruses 
likely to cycle and infect domestic 
animals such as camels coming to 
drink and rest.
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Table. Results of testing of camels for virus antibodies, by location, age group, and sex 
of camels examined, North Africa, 2009* 
Camel characteristic 
No.
samples 
No. positive for antibody 
RVFV  WNV AHSV RVFV and WNV 
Origin 
 Tata 2 0 0 0 0
 Smara-Laayoune 58 13 20 0 11
 Dakhla 40 2 9 0 1
Age group, y 
 <1 18 1 1 0 1
 1–2 25 0 1 0 0
 3–5 7 1 3 0 1
 6–10 27 6 12 0 10
 >10 23 7 12 0 0
Sex
 M 71 10 15 0 7
 F 29 5 14 0 5
Total 100 15 29 0 12
*RVFV, Rift Valley fever virus; WNV, West Nile virus; AHSV, African horse sickness virus. 
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Brucellosis, 
Taiwan, 2011
To the Editor: Human brucellosis 
is the most common zoonosis 
worldwide (1–4). The disease is 
transmitted to humans through the 
consumption of infected meat and raw 
dairy products from domestic livestock 
or by direct or indirect contact with 
infected animals (1–3). The disease is 
multisystemic and shows wide clinical 
polymorphism (2–4).
A 54-year-old woman reported 
high fever, poor appetite, epigastralgia, 
mild dysuria, generalized myalgia, and 
mild left side pain for 6 days before 
she sought care at and was admitted to 
National Taiwan University Hospital, 
Taipei, Taiwan. She had a history of 
ovarian cancer (clear cell, stage Ic), 
which had been treated with surgery 
and chemotherapy 7 years earlier at 
our hospital. She had traveled to many 
countries, most recently to Algeria 
and Morocco 2 months before this 
admission. During her stay in North 
Africa, she had close contact with 
camels, ate cheese and yogurt, and 
drank milk, even in the desert. Fever 
occurred 1 month after she returned to 
Taiwan.
On physical examination, her 
body temperature was 39.9°C, blood 
pressure was 97/68 mm Hg, and pulse 
rate was 89 beats/min. There was 
mild tenderness on palpation in the 
epigastric area. Laboratory analysis 
of serum specimens showed elevated 
levels of alanine aminotransferase 
(534 U/L), aspartate aminotransferase 
(841 U/L), and alkaline phosphatase 
(337 U/L) but a total bilirubin level 
(0.48 mg/dL) within reference limits. 
Renal function was within reference 
ranges (blood urea nitrogen 9.5 mg/
dL, creatinine 0.6 mg/dL). C-reactive 
protein was elevated (4.59 mg/dL), 
but procalcitonin level was within 
reference range (0.13 ng/mL). The 
leukocyte count was 4,710 cells/mm3, 
and hemoglobin was 11.4 g/dL. 
Serologic tests for viral hepatitis 
were negative for hepatitis B virus, 
hepatitis A virus, cytomegalovirus, 
and Epstein-Barr virus infections. 
Abdominal ultrasound indicated 
mild splenomegaly and no evidence 
of vegetation. Abdominal and pelvic 
computed tomography showed focal 
splenic infarction with splenomegaly.
Empirical ceftriaxone (1 g every 
12 h) and doxycycline (100 mg every 
12 h) were administered, and fever 
subsided 5 days later. Two aerobic 
culture bottles (BacT/ALERT, 
bioMérieux Inc., La Balme les 
Grottes, France) from different sets 
of blood cultures on the day before 
admission yielded unidentifi ed gram-
negative tiny bacilli after 2 days 
of incubation. The organism was 
identifi ed as Brucella melitensis by 
the Vitek 2 GN identifi cation system 
(bioMérieux Inc.) (probability of 
identity 99%) and was confi rmed 
by analysis of partial 16S rRNA 
gene sequencing. Two primers 
were used: 8FPL (5′-AGAGT
TTGATCCTGGCTCAG-3′) and 1492
RPL (5′-GGTTACCTTGTTACGAC
TT-3′). We compared the partial 
sequences with published sequences 
in the GenBank database by using the 
BLASTN algorithm (www.ncbi.nlm.
nih.gov/blast). The closest match was 
B. melitensis (GenBank accession 
no. CP001852.1; maximal identity 
100%). MICs were determined 
by the Etest (AB Biodisk, Solna, 
Sweden) on Mueller-Hinton agar 
(BBL, Becton Dickinson, Sparks, 
MD, USA) supplemented with 5% 
sheep blood and were interpreted 2 
days after incubation. The isolate was 
susceptible to doxycycline (MIC 0.25 
μg/mL; susceptible MICs <2 μg/mL) 
but not susceptible to trimethoprim/
sulfamethoxazole (MIC 1/19 μg/
mL; susceptible MICs <0.5 μg/mL) 
(5,6). MIC values of tigecycline and 
gentamicin were 0.125 μg/mL and 
2.0 μg/mL, respectively. A serum 
sample for examination of Brucella 
antibody by Rose Bengal test using 
B. abortus antigen (VLA Scientifi c, 
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